文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

南亚与东南亚外部质量保证网络:One Health领域参考实验室国际外部质量保证项目的经验与结果

External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

EQASIA是2020年建立的南亚与东南亚外部质量保证网络,旨在提升该区域所有One Health部门的细菌学诊断质量。2021至2023年开展六轮EQA,每轮包含WHO GLASS和FAO优先病原体组合,参加实验室24至32家。实验室总体表现75%至100%(平均93.3%,中位数93.6%),除弯曲杆菌属和肠球菌属组合外多数分离株可正确鉴定,表现随时间显著改善。

要点

  • EQASIA六轮EQA中实验室总体表现75%至100%,平均93.3%,中位数93.6%。
  • 除弯曲杆菌属和肠球菌属组合外,多数EQA组合的分离株可被分离并正确鉴定。
  • 结果显示实验室表现随时间显著改善。

核心结论

  • 微生物实验室的能力建设和质量保证在抗菌药物耐药(AMR)和One Health监测背景下尤为重要。
  • EQASIA项目有潜力验证实验室检测重要One Health病原体的表现,为有效监测遏制AMR生成可靠数据。

研究设计与样本

  • EQASIA是2020年建立的南亚与东南亚外部质量保证网络,旨在提升该区域所有One Health部门的细菌学诊断质量。
  • 2021至2023年间开展六轮EQA,每轮由不同的WHO GLASS和FAO优先病原体组合构成,涉及人类和动物健康部门。
  • 六轮EQA(EQA1-6)中每轮有24至32家实验室报名参加。

主要发现

  • 参与实验室能够分离并正确鉴定EQA组合中的多数分离株,但弯曲杆菌属和肠球菌属组合除外。
  • 实验室在六轮EQA中的总体表现介于75%至100%(平均93.3%,中位数93.6%)。
  • 获得的结果显示实验室表现随时间显著改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: External quality assurance (EQA) is an objective tool to assess laboratories' diagnostic performance and their adherence to recognized international standards. External Quality Assessment in Asia (EQASIA) is an EQA network in South and South-East Asia established in 2020 with the aim of improving the quality of bacteriology diagnostics across all One Health sectors in the region. The aim of this paper is to provide a comprehensive overview of the EQA results collected from the EQASIA network and to assess improvements among the participating laboratories. METHODS: Six EQA rounds were conducted between 2021 and 2023, each composed of different panels of WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and The Food and Agriculture Organization of the United Nations (FAO) priority pathogens of interest to both the human and animal health sector. RESULTS: Between 24 and 32 laboratories signed up for six EQA rounds (EQA1-6). Participating laboratories were able to isolate and correctly identify most of the isolates across the EQA panels except for the Campylobacter spp. and Enterococcus spp. panels. The overall performance of laboratories across the six EQAs was between 75% and 100% (average 93.3% and median 93.6%). The obtained results showed a significant improvement in laboratories' performance over time. CONCLUSIONS: Laboratory capacity development and quality assurance in a microbiology laboratory are of particular importance especially in the context of antimicrobial resistance (AMR) and One Health surveillance. The EQASIA programme has the potential to validate laboratories' performance in detecting important One Health pathogens, generating reliable data for effective surveillance to curb AMR.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Kostyanev T, Al-Mir H, Prifti K, et al. External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories. J Antimicrob Chemother. 2025. PMID: 39902655. doi:10.1093/jac/dkaf032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。